WITH EMBRYO BASE EDITING, CHINA GETS ANOTHER CRISPR FIRST

from NCER: In a breakthrough first, Chinese scientists have just boldly used CRISPR to edit diseased genes in viable human embryos created through IVF. Because international ethical guidelines for research are not followed in China, they are comfortable with editing IVF embryos so as to affect future generations, referred to as germline gene editing. Any changes, whether beneficial or harmful, would be inherited by future generations, and therefore would not only violate the rights of …